Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines - Lenz,H.J.; Van Cutsem,E.; Khambata-Ford,S. (J Clin Oncol, 2006)